The KRAS-variant and Second Cancer Risk
A second cancer diagnosis is often a concern of cancer patients. Although it seems unfair to have to go through the whole cancer journey again, the good news is that it is…
Read More ➝
KRAS-variant
Understanding different genetic causes of cancer: BRCA variants vs. the KRAS-variant
This post explores BRCA variants vs. the KRAS-variant and is part two of our series on understanding the different genetic causes of cancer. In part one of our series, we compared genetic…
Read More ➝
Understanding the different causes of cancer: genetic variants vs. genetic mutations
Learn more about how our genes play a role in cancer development in this two-part series comparing different genetic variants and genetic mutations. For Part 1, we’ll discuss the KRAS-variant and KRAS…
Read More ➝
Clinical Trial for Patients with the KRAS-variant and HNSCC
Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of HRT in the KRAS-variant patients, and even autoimmunity! Now, we want…
Read More ➝
If I participate in a study will you send me my KRAS-variant results?
We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no….
Read More ➝
Do I need to get tested for KRAS-variant if I’m BRCA positive?
We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant?…
Read More ➝
New Research: How Inherited DNA -Based Mutations Impact Immunotherapy
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we have spoken a…
Read More ➝
What You Need to Know About Estrogen and the KRAS-variant
Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation that predicts an increased risk of cancer. Following this breakthrough, Dr. Weidhaas and…
Read More ➝The KRAS-Variant and Breast Cancer: Understanding Genetic Risk
Last updated: 11/25/2025 Most people are familiar with BRCA1 and BRCA2, the genes best known for their link to hereditary breast cancer. Discoveries of these mutations have offered important clues about inherited…
Read More ➝
The truth about GWAS and the KRAS-variant
Although much of the world has accepted that GWAS studies, which use an outdated technology looking at large amounts of data, have failed to find any functional mutations, this approach has twice…
Read More ➝
